provid 44 oral paste - paieškos rezultatas

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

oxycodone hydrochloride- oxycodone hydrochloride solution

roxane laboratories, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 100 mg in 5 ml - oxycodone hydrochloride oral solution usp, 100 mg per 5 ml (20 mg/ml ) is an opioid analgesic indicated for the management of moderate to severe acute and chronic pain in opioid-tolerant patients. oxycodone hydrochloride oral solution usp, 100 mg per 5 ml (20 mg/ml) may cause fatal respiratory depression when administered to patients not previously exposed to opioids. patients considered to be opioid tolerant are those who are taking at least 30 mg of oral oxycodone per day, or at least 60 mg oral morphine per day, or at least 12 mg hydromorphone per day, or an equianalgesic dose of another opioid, for a week or longer. oxycodone hydrochloride oral solution usp is contraindicated in patients with respiratory depression in the absence of resuscitative equipment. oxycodone hydrochloride oral solution usp is contraindicated in any patient who has or is suspected of having paralytic ileus. oxycodone hydrochloride oral solution usp is contraindicated in patients with acute or severe bronchial asthma or hypercarbi

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

syrisal 292.5mg/5ml (1mmol/ml) oral solution

1mmol/ml) oral solution (thame laboratories ltd - sodium chloride - oral solution - 58.5mg/1ml

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

sildenafil for oral suspension- sildenafil citrate powder, for suspension

cipla usa inc. - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil for oral suspension is indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil for oral suspension was added to background epoprostenol therapy [see clinical studies (14)] . studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii–iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use : adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14)] . sildenafil for oral suspension is contraindicated in patients with: - concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2)] . - concomitant use of riociguat,

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

value plus expel yellow tube allwormer paste for horses

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

equimax elevation oral broad spectrum wormer and boticide paste for horses

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

promectin plus lv allwormer paste for horses (300 kg - 600 kg)

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

calesulpha-t oral paste for horses

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fluximine paste

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

moramectin allwormer paste for horses

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac horse wormer oral broad spectrum wormer and boticide paste for horses